Treatment of Focal Ventricular Tachycardias Using a Pulsed Field Ablation From a Point Ablation Catheter Short Title FOCUS-PFA

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to examine the use of a point ablation catheter (Farapoint, Boston Scientific) in the mapping and ablation of focal ventricular arrhythmias (premature ventricular contractions or ventricular tachycardia) using pulsed field energy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

∙ Subjects must meet ALL of the following inclusion criteria to be eligible for participation in this clinical investigation:

• Patient is planned for a catheter ablation procedure to ablate either:

‣ Premature ventricular contractions (PVCs) and a class I or IIa indication for catheter ablation of PVCS according to the 2019 HRS/EHRA/APHRS/LAHRS guidelines

⁃ Symptomatic Sustained Monomorphic Ventricular Tachycardia

• Able and willing to provide written consent and comply with all testing and follow-up requirements

• Above 18 years of age

Locations
United States
New York
Icahn School of Medicine at Mount Sinai
RECRUITING
New York
Contact Information
Primary
Betsy Ellsworth, MSN
betsy.ellsworth@mountsinai.org
347-498-3855
Backup
Devin Chamberlain, BS
devin.chamberlain@mountsinai.org
347-498-3855
Time Frame
Start Date: 2025-01-07
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 30
Treatments
Experimental: Ablation using study catheter
All patients will undergo a standard ablation protocol using the study catheter (Farapoint)
Sponsors
Leads: Vivek Reddy
Collaborators: Boston Scientific Corporation

This content was sourced from clinicaltrials.gov